BL
INSM icon

Bleichroeder LP’s Insmed INSM Stock Holding History

Bleichroeder LP’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-325,000
Closed -$8.82M – 77
2024
Q1 		$8.82M Hold
325,000
– – 2.2% 12
2023
Q4 		$10.1M Hold
325,000
– – 2.24% 12
2023
Q3 		$8.21M Hold
325,000
– – 2.02% 13
2023
Q2 		$6.86M Buy
325,000
+299,399
+1,169% +$5.68M 1.39% 17
2023
Q1 		$436K Buy
+25,601
New +$497K 0.09% 38

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Bleichroeder LP's INSM Position: Q2 2024 in Review

Bleichroeder LP sold out of Insmed (INSM) in Q2 2024, closing a stake of 325,000 shares — an estimated $8.82M sold.

Bleichroeder LP first reported a position in INSM in Q1 2023 and held it in 5 quarters. The position peaked at $10.1M in Q4 2023. 378 funds tracked by Wall St. Rank hold INSM as of Q2 2024.

  • Bleichroeder LP reported no remaining Insmed position as of Q2 2024 after selling out during the quarter.
  • Bleichroeder LP sold 325,000 Insmed shares in Q2 2024, an estimated $8.82M.
  • Bleichroeder LP first reported a position in Insmed in Q1 2023 and held it in 5 quarters.
  • Bleichroeder LP's Insmed position peaked at $10.1M in Q4 2023.
  • 378 funds tracked by Wall St. Rank held Insmed as of Q2 2024.

Based on Bleichroeder LP's 13F filing for Q2 2024, filed 13 Aug 2024.